Pharma Focus Asia

Repligen

LATEST NEWSRead more...

21

Jun 2024

NephroDI Therapeutics Receives Investment from Sound Bioventures to Hasten Development of NDI-5001 for Pediatric Orphan Kidney Disease

NephroDI Therapeutics a pharmaceutical company in the advanced stages of development focusing on kidney disorders has received a Series A investment from Sound Bioventures a life sciences venture

21

Jun 2024

Sarepta Therapeutics Announces FDA Expansion of ELEVIDYS for Duchenne Muscular Dystrophy Patients Aged 4 and Up

Sarepta Therapeutics Inc a leading company in precision genetic medicine for rare diseases has announced that the US Food and Drug Administration has expanded the indication for ELEVIDYS

21

Jun 2024

SK Bioscience Introduces South Korea’s Inaugural AI-Driven Experiment Design System

SK Bioscience is pioneering vaccine development through advanced AI technology Their new IT system ADO represents a major advancement in South Koreas

20

Jun 2024

Golidocitinib Receives Approval in China as the First JAK1-Selective Inhibitor for Treating Relapsed or Refractory Peripheral T-Cell Lymphoma

Dizal a biopharmaceutical company dedicated to developing new treatments for cancer and immunological diseases announced that golidocitinib has received approval from the National Medical Products

20

Jun 2024

Roche Launches New Test for Early Detection of B-cell Lymphoma

Roche has recently launched the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay the first ISH test approved for clinical use in countries that accept the CE Mark This assay aids pathologists in distinguishing between Bcell malignancies and normal immune responses to infections

Solovpe

press releasesRead more...

21

Jun 2024

Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda

Ascentage Pharma a global biopharmaceutical company engaged in developing novel therapies for cancer chronic hepatitis B and agerelated diseases announced today that the agreed equity investment by Takeda

21

Jun 2024

Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies

Cryoport Inc a global leader in supply chain solutions for the life sciences and Minaris Regenerative Medicine Co Ltd a global contract development and manufacturing organization

21

Jun 2024

20

Jun 2024

Medivir Selects Global CRO Partner for Upcoming Phase 2b Study in HCC With Fostrox + Lenvima and Initiates Study Feasibility

Medivir AB a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need announced today that it has selected a global

20

Jun 2024

Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health

Recently Professor Jianping Weng of the University of Science and Technology of China and President of Anhui Medical University and his team of researchers from USTC Southern Medical University

20 - 22

Jun 2024

20 - 22

Jun 2024

24 - 24

Jun 2024

24 - 25

Jun 2024

25 - 26

Jun 2024

Asia Healthcare Week (AHW)

Suntec Convention & Exhibition Centre, Singapore

25 - 27

Jun 2024

3rd World ADC Asia

Incheon, South Korea

26 - 27

Jun 2024

26 - 27

Jun 2024

Future Labs

Basel, Switzerland

magazine-slider-image
Cytiva - Supor Prime filters
MFA + MMA 2024
Asia Healthcare Week 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

  • 3

    Harnessing Artificial Intelligence

    Anita-Ioana Visan

    Scientific Researcher 2nd degree, Laser-Surface-Plasma Interactions (LSPI) Laboratory

    Irina Negut

    Scientific Researcher 2nd degree, National Institute for Lasers, Plasma and Radiation Physics (INFLPR)

KNOWLEDGE BANK

  • Interviews

    mRNA Platforms as Diagnostics and Therapeutics for Human Infertility Treatments

    Associate Professor, Department of Biology, Khalifa University

    Junaid Kashir is an Associate Professor in the Department of Biology at Khalifa University andhas previously chaired multiple researchadministrative committees He has been heavilyinvolved in multiple programs for training graduate clinical embryology students Dr Kashirsresearch aims to develop therapeuticdiagnostic interventions to treat infertility and understandembryology
  • Case Studies

    Viral Clearance For Biopharmaceutical Downstream Processes

    AbstractViral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals These studies are a key component of risk mitigation to reduce the potential for iatrogenic transmission of pathogenic viruses This paper reviews regulatory guidance and practical strategies for designing viral clearance studies Ess

  • White Papers

    The New Normal: How COVID-19 Became the Catalyst for Change

    When COVID disrupted life sciences solutions were needed in realtime As the pandemic grew so did the need to innovate Workers met the challenges They completed tasks fulfilled inspections and remained vigilant in fulfilling regulatory requirements This paper presents findings from a roundtable hosted by PharmaLex

EDITORIAL SECTION